Payers struggle to determine the appropriate criteria for covering innovative treatments and providers want to increase patient access. Patients’ lives can hang in the balance.
Onboarding new oncology patients can be a delicate process to help them prepare for their care journey. Here are the first steps.
While promising new options keep entering the scene, high costs can be problematic to patients and healthcare organizations. Here are some ways to cope.
The latest lymphoma research continues to bring new hope for patents, families and care providers. In looking at such advances, here are four things to know.
Medical malpractice companies partner to provide a detailed analysis of breast cancer medical malpractice claims. The findings may surprise you.
Basket trials are designed to test therapies that target a specific genetic mutation found in the tumor, regardless of tumor histology. This emerging trend raises a number of key questions for the industry.
If it's true that a picture is worth a thousand words, the same can be said for numbers. For any healthcare executive, a look at relevant statistics can be revealing. Here are some of the top stats to know.
Researchers and scientists continue to develop and test new treatments for these fatal conditions. Here’s a look at some major developments in these areas.
When it comes to promising areas in the treatment of lymphoma and other blood cancers, gene therapy may be at the top of the list. Here’s why.
Two oncology practices have wish list items for payers. Find out what they are.